These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6298119)

  • 1. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome.
    Harada S; Bechtold T; Seeley JK; Purtilo DT
    Int J Cancer; 1982 Dec; 30(6):739-44. PubMed ID: 6298119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
    Yasuda N; Lai PK; Rogers J; Purtlo DT
    Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
    Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
    J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
    Sakamoto K; Seeley JK; Lindsten T; Sexton J; Yetz J; Ballow M; Purtilo DT
    J Immunol; 1982 Feb; 128(2):904-7. PubMed ID: 6274962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E; Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection.
    Okano M; Thiele GM; Kobayashi RH; Davis JR; Synovec MS; Grierson HL; Jaffe HS; Purtilo DT
    J Clin Immunol; 1989 Jan; 9(1):48-54. PubMed ID: 2539385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
    J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.
    Bottino C; Falco M; Parolini S; Marcenaro E; Augugliaro R; Sivori S; Landi E; Biassoni R; Notarangelo LD; Moretta L; Moretta A
    J Exp Med; 2001 Aug; 194(3):235-46. PubMed ID: 11489943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
    Masucci G; Berkel I; Masucci MG; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
    J Clin Immunol; 1984 Sep; 4(5):369-82. PubMed ID: 6092413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory T cells in males vulnerable to Epstein-Barr virus with the X-linked lymphoproliferative syndrome.
    Lai PK; Yasuda N; Purtilo DT
    Am J Pediatr Hematol Oncol; 1987; 9(2):179-82. PubMed ID: 3035958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
    Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
    Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
    Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.